Liver King Is Being Sued By His Fans For $25 Million Because He "Tricked" Them Into Buying His Muscle-Building Supplements While He Was Taking Steroids
Liver King was recently exposed by another fitness influencer for using $12,000 worth of human growth hormones and steroids per month. Now, his fans are suing him for $25 million.
Brian Johnson, commonly known as "Liver King," is now being sued by his customers, according to the New York Post. The influencer often claimed that his muscular physique was due to his ancestral diet and way of living. The 45-year-old finally admitted in a video in early December that he was, in fact, using steroids and not natural as he previously claimed.
Since the revelation, one man named Christopher Altomare has filed a lawsuit against Liver King and his companies – Ancestral Supplements, LLC and The Fittest Ever, LLC – for a whopping $25 million. Altomare claims that Johnson falsely advertised his supplements and encouraged individuals to assume a "dangerous and life-threatening diet" that allegedly caused his customers to suffer from "severe" food-borne illnesses.
Liver King taught his audience the "Nine Ancestral Tenets," which promotes an Ancestral diet and lifestyle. "Liver King persuaded millions of consumers to adhere to, or abide by, the Eat Tenet by repeatedly making representations to consumers that his near-perfect physique, and optimal health, were solely attributable to his adoption of the Ancestral Tenets, predominantly the Eat Tenet," the lawsuit writes.
Liver King famously would deny allegations of his steroid use in the past. "I think him saying that [Liver King on steroids] is dangerous," he was quoted to have said. "You know, I want to set the record straight. I would love the opportunity to talk to him face-to-face. To really get deep into the nine ancestral tenets... I don't touch this stuff [steroids], I've never done this stuff. I'm not going to do this stuff."
The New York Post reached out to Johnson's representatives. “We have not been served with any lawsuit at this point and it would not be appropriate for us to comment on pending litigation," they told the Post.
Don’t miss anything! Sign up for our weekly newsletter and get curated content weekly!